ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

Cancer Commission Surveying for Pill, Hepatoma Association

October 1, 1976

ACCC Annual Meeting Jan. 27-29; Upton To speak

November 4, 1977